Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

by Nicolas Epaillard, Pauline Parent, Yohann Loriot, Pernelle Lavaud, E-B. Vera-Cea, Nieves Martinez-Chanza, Alejo Rodriguez-Vida, Clement Dumont, Rebeca Lozano, Rebeca Lozano, Casilda Llácer, Raffaele Ratta, Stephane Oudard, Constance Thibault, Edouard Auclin
Published 2021-05-01

Detection of <i>TP53</i> and <i>PIK3CA</i> Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis

by Begona Jimenez Rodriguez, Gema Diaz Córdoba, Alicia Garrido Aranda, Martina Álvarez, Luis Vicioso, Casilda Llácer Pérez, Cristina Hernando, Begoña Bermejo, Ana Julve Parreño, Ana Lluch, Matthew B. Ryder, Frederick S. Jones, Johannes Fredebohm, Frank Holtrup, María Isabel Queipo-Ortuño, Emilio Alba
Published 2019-08-01

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

by Rebeca Lozano, David Lorente, Isabel M. Aragon, Nuria Romero-Laorden, Paz Nombela, Joaquim Mateo, Alison H. M. Reid, Ylenia Cendón, Diletta Bianchini, Casilda Llacer, Shahneen K. Sandhu, Adam Sharp, Pasquale Rescigno, Teresa Garcés, Maria I. Pacheco, Penelope Flohr, Christophe Massard, Pedro P. López-Casas, Elena Castro, Johann S. de Bono, David Olmos
Published 2021-05-01